JATAN RAYTHATHA: Open Payments
NPI 1144771866 · DOVER, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,949 in 102 payments from 16 companies in 2025. Trend: 2023 $1,836 · 2024 $1,491 · 2025 $1,949
Food & beverage: $1,910Education: $40
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 8 | $329 |
| QOL Medical, LLC | 20 | $320 |
| ABBVIE INC. | 16 | $266 |
| Ardelyx, Inc. | 14 | $241 |
| Janssen Biotech, Inc. | 12 | $198 |
| Lilly USA, LLC | 5 | $117 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $113 |
| Phathom Pharmaceuticals, Inc. | 8 | $84 |
| PFIZER INC. | 3 | $51 |
| Gilead Sciences, Inc. | 2 | $49 |
Products named: REZDIFFRA, Sucraid, IBSRELA, TREMFYA, CREON, LINZESS, VOQUEZNA, ENTYVIO.
Industry payments across DE — which companies pay providers there.
